Table of Contents

1 Study Coverage

• 1.1 Amiodarone Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Amiodarone Market Size Growth Rate by Product
  • 1.4.2 Tablet
  • 1.4.3 Capsule
  • 1.4.4 Injection
• 1.5 Market by End User
  • 1.5.1 Global Amiodarone Market Size Growth Rate by End User
  • 1.5.2 Cardiac Arrest
  • 1.5.3 Ventricular Tachycardia
  • 1.5.4 Atrial Fibrillation
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Amiodarone Market Size
  • 2.1.1 Global Amiodarone Revenue 2014-2025
  • 2.1.2 Global Amiodarone Sales 2014-2025
• 2.2 Amiodarone Growth Rate by Regions
  • 2.2.1 Global Amiodarone Sales by Regions
  • 2.2.2 Global Amiodarone Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Amiodarone Sales by Manufacturers
  • 3.1.1 Amiodarone Sales by Manufacturers
  • 3.1.2 Amiodarone Sales Market Share by Manufacturers
  • 3.1.3 Global Amiodarone Market Concentration Ratio (CR5 and HHI)
• 3.2 Amiodarone Revenue by Manufacturers
  • 3.2.1 Amiodarone Revenue by Manufacturers (2014-2019)
  • 3.2.2 Amiodarone Revenue Share by Manufacturers (2014-2019)
• 3.3 Amiodarone Price by Manufacturers
• 3.4 Amiodarone Manufacturing Base Distribution, Product Types
  • 3.4.1 Amiodarone Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Amiodarone Product Type
  • 3.4.3 Date of International Manufacturers Enter into Amiodarone Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Amiodarone Sales by Product
• 4.2 Global Amiodarone Revenue by Product
• 4.3 Amiodarone Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Amiodarone Breakdown Data by End User

6 North America

• 6.1 North America Amiodarone by Countries
  • 6.1.1 North America Amiodarone Sales by Countries
  • 6.1.2 North America Amiodarone Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Amiodarone by Product
• 6.3 North America Amiodarone by End User

7 Europe

• 7.1 Europe Amiodarone by Countries
  • 7.1.1 Europe Amiodarone Sales by Countries
  • 7.1.2 Europe Amiodarone Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Amiodarone by Product
• 7.3 Europe Amiodarone by End User

8 Asia Pacific

• 8.1 Asia Pacific Amiodarone by Countries
  • 8.1.1 Asia Pacific Amiodarone Sales by Countries
  • 8.1.2 Asia Pacific Amiodarone Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Amiodarone by Product
• 8.3 Asia Pacific Amiodarone by End User

9 Central & South America

• 9.1 Central & South America Amiodarone by Countries
  • 9.1.1 Central & South America Amiodarone Sales by Countries
  • 9.1.2 Central & South America Amiodarone Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Amiodarone by Product
• 9.3 Central & South America Amiodarone by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Amiodarone by Countries
  • 10.1.1 Middle East and Africa Amiodarone Sales by Countries
  • 10.1.2 Middle East and Africa Amiodarone Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Amiodarone by Product
• 10.3 Middle East and Africa Amiodarone by End User

11 Company Profiles

• 11.1 Sanofi
  • 11.1.1 Sanofi Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Sanofi Amiodarone Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Sanofi Amiodarone Products Offered
  • 11.1.5 Sanofi Recent Development
• 11.2 Sawai Pharmaceutical
  • 11.2.1 Sawai Pharmaceutical Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Sawai Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Sawai Pharmaceutical Amiodarone Products Offered
  • 11.2.5 Sawai Pharmaceutical Recent Development
• 11.3 Wyeth Pharmaceuticals (Pfizer)
  • 11.3.1 Wyeth Pharmaceuticals (Pfizer) Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Wyeth Pharmaceuticals (Pfizer) Amiodarone Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Wyeth Pharmaceuticals (Pfizer) Amiodarone Products Offered
  • 11.3.5 Wyeth Pharmaceuticals (Pfizer) Recent Development
• 11.4 Mylan Pharmaceuticals
  • 11.4.1 Mylan Pharmaceuticals Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Mylan Pharmaceuticals Amiodarone Products Offered
  • 11.4.5 Mylan Pharmaceuticals Recent Development
• 11.5 Arrow Pharma Pty Ltd
  • 11.5.1 Arrow Pharma Pty Ltd Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Arrow Pharma Pty Ltd Amiodarone Products Offered
  • 11.5.5 Arrow Pharma Pty Ltd Recent Development
• 11.6 Roemmers
  • 11.6.1 Roemmers Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Roemmers Amiodarone Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Roemmers Amiodarone Products Offered
  • 11.6.5 Roemmers Recent Development
• 11.7 Cipla Pharmaceutical
  • 11.7.1 Cipla Pharmaceutical Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Cipla Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Cipla Pharmaceutical Amiodarone Products Offered
  • 11.7.5 Cipla Pharmaceutical Recent Development
• 11.8 Shanghai Pharmaceuticals
  • 11.8.1 Shanghai Pharmaceuticals Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Shanghai Pharmaceuticals Amiodarone Products Offered
  • 11.8.5 Shanghai Pharmaceuticals Recent Development
• 11.9 North China Pharmaceutical Company
  • 11.9.1 North China Pharmaceutical Company Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 North China Pharmaceutical Company Amiodarone Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 North China Pharmaceutical Company Amiodarone Products Offered
  • 11.9.5 North China Pharmaceutical Company Recent Development
• 11.10 Harbin Pharmaceutical Group
  • 11.10.1 Harbin Pharmaceutical Group Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Harbin Pharmaceutical Group Amiodarone Products Offered
  • 11.10.5 Harbin Pharmaceutical Group Recent Development

12 Future Forecast

• 12.1 Amiodarone Market Forecast by Regions
  • 12.1.1 Global Amiodarone Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Amiodarone Revenue Forecast by Regions 2019-2025
• 12.2 Amiodarone Market Forecast by Product
  • 12.2.1 Global Amiodarone Sales Forecast by Product 2019-2025
  • 12.2.2 Global Amiodarone Revenue Forecast by Product 2019-2025
• 12.3 Amiodarone Market Forecast by End User
• 12.4 North America Amiodarone Forecast
• 12.5 Europe Amiodarone Forecast
• 12.6 Asia Pacific Amiodarone Forecast
• 12.7 Central & South America Amiodarone Forecast
• 12.8 Middle East and Africa Amiodarone Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Amiodarone Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.
The global Amiodarone market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Amiodarone market based on company, product type, end user and key regions.

This report studies the global market size of Amiodarone in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Amiodarone in these regions.
This research report categorizes the global Amiodarone market by top players/brands, region, type and end user. This report also studies the global Amiodarone market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Sawai Pharmaceutical
Wyeth Pharmaceuticals (Pfizer)
Mylan Pharmaceuticals
Arrow Pharma Pty Ltd
Roemmers
Cipla Pharmaceutical
Shanghai Pharmaceuticals
North China Pharmaceutical Company
Harbin Pharmaceutical Group

Market size by Product
Tablet
Capsule
Injection
Market size by End User
Cardiac Arrest
Ventricular Tachycardia
Atrial Fibrillation
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Amiodarone market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Amiodarone market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Amiodarone companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Amiodarone submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Amiodarone are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Amiodarone market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.